A New Tool for Helping Labs Improve Diversity in Clinical Trials
Rachel Rangel, AuD, discusses a new toolkit to help laboratory professionals ensure diversity and inclusion is addressed in their research.
Open Content
Subscribe today for access to
Articles and Reports
G2 Intelligence Has Some Exciting News to Share!
G2 Intelligence to change subscription model to better serve the laboratory industry with more analysis and insight
Is a Newly Proposed Rule Meant to Stop Healthcare Consolidation?
The new rule put forth by the FTC and DOJ would make mergers and acquisitions much more difficult to achieve.
Compliance Tool: Healthcare Equity Plan Model Form
Follow the steps in this form to help you develop and implement an effective healthcare equity plan for your lab.
Ex-CEO of Health Clinic Found Guilty of Medicaid Fraud
In this week’s enforcement roundup, the former executive was convicted of healthcare fraud relating to mental health diagnosis and treatment.
‘Digital Mask’ Tech Could Help Solve Patient Privacy Issues
A new technology could help protect patients’ privacy when it comes to the use of facial images in medical diagnoses.
Amazon Shuts Down Telehealth Service
Retailer stubs a toe on its way to disrupting health care.
New FDA Bill Bypasses LDTs Reform—Again
It now appears that Congress is going to dash the lab industry’s hopes yet again by reauthorizing FDA user fees without VALID.
Clinical Lab Owner Pleads Guilty to Three Healthcare Fraud Schemes
The owner of several clinical labs and other businesses will pay big for the schemes that involved money laundering, kickbacks, and fraud.
House Passes Legislation to Better MA Prior Authorization Process
According to healthcare groups, the Improving Seniors’ Timely Access to Care Act would help fix problems with current system.
Is Your Lab Ready to Comply with the New Equity Standard?
You’ll need a healthcare equity plan to maintain Joint Commission accreditation after Jan. 1.
US Government Suspends Free At-Home COVID-19 Antigen Test Program
Biden administration blames the decision on Congress’ failure to provide the additional funding necessary to keep the program going.
Arrayit President Convicted in Massive Allergy and COVID-19 Testing Scam
Mark Schena was found guilty of defrauding investors, as well as running an illegal kickback and healthcare fraud scheme.
